🇺🇸 FDA
Patent

US 8715653

Modulation of Rhamm (CD168) for selective adipose tissue development

granted A61PA61P17/02A61P19/00

Quick answer

US patent 8715653 (Modulation of Rhamm (CD168) for selective adipose tissue development) held by The Regents of the University of California expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P17/02, A61P19/00, A61P21/00, A61P3/04